Inventor · disambiguated record
Marina Cavazzana
Also filed as: CAVAZZANA MARINA
4 granted patents·13 pending applications·1 citations·filing 2015–2023
61Inventor score
Files withINST NAT SANTE RECH MED8ASSIST PUBLIQUE - HOPITAUX DE PARIS3HOPITAUX PARIS ASSIST PUBLIQUE3CELLECTIS SA1INSERM INSTITUT NATIONAL DE LA SANTE ET LA RECH MEDICALE1
Top patents by PatentIndex Score
17 records- 0179US11426430B2Method for generating T cells progenitorsASSIST PUBLIQUE—HOPITAUX DE PARIS·Filed 2020·Granted Aug 30, 2022·1 cites·18 claims
- 0274US2023293586A1Method for generating t cells progenitorsHOPITAUX PARIS ASSIST PUBLIQUE·Filed 2023·Application pending·0 cites
- 0367US11642376B2Method for generating T cell progenitorsASSIST PUBLIQUE—HOPITAUX DE PARIS·Filed 2021·Granted May 9, 2023·0 cites·29 claims
- 0467US11638723B2Method for generating T cells progenitorsASSIST PUBLIQUE—HOPITAUX DE PARIS·Filed 2021·Granted May 2, 2023·0 cites·5 claims
- 0562US2025288673A1Gene therapy for the treatment of activated pi3kinase delta syndrome type 1 (apds1)CELLECTIS SA·Filed 2023·Application pending·0 cites
- 0660US2020046767A1Method for generating t cells progenitorsHOPITAUX PARIS ASSIST PUBLIQUE·Filed 2018·Application pending·0 cites
- 0756US2025084389A1Methods of inducing cell death of a population of solid tumor cellsINST NAT SANTE RECH MED·Filed 2023·Application pending·0 cites
- 0853US2025283174A1Methods for assessing the exhaustion of hematopoietic stem cells induced by chronic inflammationINST NAT SANTE RECH MED·Filed 2023·Application pending·0 cites
- 0951US2023357769A1Bifunctional lentiviral vectors allowing the bs-globin silencing and expression of an anti-sickling hbb and uses thereof for gene therapy of sickle cell diseaseINST NAT SANTE RECH MED·Filed 2021·Application pending·0 cites
- 1047US2023136699A1Gene therapy for maple syrup urine diseaseINST NAT SANTE RECH MED·Filed 2021·Application pending·0 cites
- 1145US2022265781A1Methods for inducing full ablation of hematopoiesisINST NAT SANTE RECH MED·Filed 2020·Application pending·0 cites
- 1245US2022160788A1Bifunctional vectors allowing bcl11a silencing and expression of an anti-sickling hbb and uses thereof for gene therapy of b-hemoglobinopathiesINST NAT SANTE RECH MED·Filed 2020·Application pending·0 cites
- 1342US2023279438A1Base editing approaches for the treatment of betahemoglobinopathiesINSERM INSTITUT NATIONAL DE LA SANTE ET LA RECH MEDICALE·Filed 2021·Application pending·0 cites
- 1442US2022168394A1Methods of inducing or restoring immune toleranceINST NAT SANTE RECH MED·Filed 2020·Application pending·0 cites
- 1542US2022017919A1Recombinant vectors suitable for the treatment of ipex syndromeINST NAT SANTE RECH MED·Filed 2019·Application pending·0 cites
- 1631US12071635B2Method for generating T-cell progenitorsHOPITAUX PARIS ASSIST PUBLIQUE·Filed 2015·Granted Aug 27, 2024·0 cites·16 claims
- 1729US2019209567A1A Specific Trifluoroethyl Quinoline Analogue For Use In The Treatment of APDSUCB BIOPHARMA SPRL·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Marina Cavazzana files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →